Vitalipid N Injections – Exporting Opportunity

Type of document: Contract Notice
Country: United Kingdom

1. Title: VITALIPID N INJECTIONS – EXPORTING OPPORTUNITY
2. Awarding Authority: Secretary of State for Business, Innovation & Skills acting on behalf of UK Trade & Investment (UKTI), GB. Web:
3. Contract type: Supply contract
4. Description: Opportunity type: Public Sector
Industry: Healthcare services, Pharmaceuticals and biotechnology
Local authority tender for the supply of Vitalipid N injections.
You must be able to supply the following minimum quantities of Vitalipid N (or equivalent) injections:
1. A minimum quantity of 70,000 ampoules/vials of Vitalipid N Infant (or equivalent) injection, 10ml, preservative free.
Each ml contains:
Retinol 69 mcg
Ergocalciferol 1mcg
Alpha-tocopherol 0.64 mg
Phytomenadione 20 mcg
2. A minimum quantity of 88,200 ampoules/vials of Vitalipid N Adult (or equivalent) injection, 10ml, preservative free.
Each ml contains:
Retinol 99 mcg
Ergocalciferol 0.5 mcg
Alpha-tocopherol 0.91 mg
Phytomenadione 15 mcg
Requirements are:
the immediate container and all levels of packaging of the actual sales pack must include an English translation
the expiration date must be expressed in English and/or Arabic numerals in a clear and comprehensible format
A 3 year contract with a possible extension of up to 24 months.
You must be a UK registered company.
5. CPV Code(s): 33600000, 33690000, 33692500
6. NUTS code(s): UKC, UKD, UKE, UKF, UKG, UKH, UKI, UKJ, UKK, UKL, UKM, UKN
7. Main site or location of works, main place of delivery or main place of performance: Hong Kong
8. Reference attributed by awarding authority: Not provided.
9. Estimated value of requirement: Not provided.
10. Opportunity closing date(Hong Kong Time) 14.3.2025 (12:00).
11. Address to which they must be sent: For further information regarding the above contract notice please visit:
12. Other information: TKR-2025129-EX-1835193